Results 91 to 100 of about 14,613 (227)

First‐Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta‐Analysis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundThere is no consensus on the most effective and best tolerated first‐line antiarrhythmic treatment for fetal tachyarrhythmia. The purpose of this systematic review and meta‐analysis was to compare the efficacy, safety, and fetal–maternal ...
Tarek Alsaied, Shankar Baskar, Munes Fares, Fares Alahdab, Richard J Czosek, Mohammad Hassan Murad, Larry J Prokop, Allison A Divanovic   +7 more
doaj   +1 more source

Hot Tub Lung: Misdiagnosed Hypersensitivity Pneumonitis Revealing a Mycobacterial Aetiology—A Case Report and Literature Review

Respirology Case Reports, Volume 14, Issue 9, September 2026.
Our case describes chronic daily exposure with histologic detection of rare MAC organisms, illustrating the spectrum and possible coexistence between hypersensitivity and infection, emphasising the diagnostic and therapeutic complexity of this uncommon disease.
Fadi Abualhommos, Rahaf Fetyani, Yasmeen Butt, Michael Gotway, Abeer Almajali, Jehad Azar   +5 more
wiley   +1 more source

Oral flecainide is effective in management of refractory tachycardia in infants

Indian Heart Journal, 2013
Background: Propranolol and digoxin have been used as first line drugs for treatment of supraventricular tachycardia (SVT) in infants. Flecainide and other drugs have been effective as a second line treatment for controlling refractory SVT.
Vikas Kohli
doaj   +1 more source

Systemic medications associate with surgically treated cataract among adults over 50 years in Finland

Acta Ophthalmologica, Volume 104, Issue 6, Page e630-e647, September 2026.
Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen, Jari Haukka, Tuomas Lilius, Sirpa Loukovaara   +3 more
wiley   +1 more source

Decreased milk drinking causing flecainide toxicity in an older child

, 2012
Flecainide is a class IC antiarrhythmic agent, used frequently in all age groups for the treatment of tachyarrhythmias. Flecainide blocks the voltage-gated sodium channel in the myocardium, leading to prolongation of depolarisation resulting in slowed ...
Barton, C, Mangat, J, Thompson, B, Hawcutt, DB   +3 more
core   +1 more source

Flecainide Versus Procainamide in Electrophysiological Study in Patients With Syncope and Wide QRS Duration.

JACC Clinical Electrophysiology, 2019
OBJECTIVES This study sought to compare the differences between procainamide and flecainide to stress the His-Purkinje system during electrophysiological study (EPS) in patients with syncope and bundle branch block (BBB).
Ivo Roca‐Luque, Jaume Francisco-Pasqual, G. Oristrell, J. Rodríguez-García, A. Santos-Ortega, Gabriel Martín-Sánchez, N. Rivas-Gándara, J. Pérez-Rodon, I. Ferreira-González, D. Garcia-Dorado, Á. Moya-Mitjáns   +10 more
semanticscholar   +1 more source

Ventricular Tachycardia Ablation in Structural Heart Disease With LVEF > 35%: Clinical Outcomes and Recurrence Patterns

Journal of Cardiovascular Electrophysiology, Volume 37, Issue 9, Page 2031-2038, September 2026.
ABSTRACT Background In patients with structural heart disease (SHD) and moderately impaired left ventricular ejection fraction (LVEF > 35%), data on outcomes after ventricular tachycardia (VT) ablation remain limited. This analysis focuses on VT recurrence after ablation in patients presenting with sustained VT and LVEF > 35% within a secondary ...
Said‐Elias Waezsada, Moneeb Khalaph, Martin Braun, Thomas Fink, Vanessa Sciacca, Nadica Trajkovska, Philipp Lucas, Ersan Akkaya, Maxim Didenko, Mustapha El Hamriti, Guram Imnadze, Denise Guckel, Christian Sohns, Philipp Sommer, Angeliki Darma   +14 more
wiley   +1 more source

Flecainide use in arrhythmic patients who have structural heart disease

Therapeutic Advances in Drug Safety
Background: Current guidelines recommend the use of only on a limited basis in patients with normal or minimal structural heart disease. The CAST study, the only randomized controlled trials, showed increased mortality from long-term flecainide use in ...
Naruepat Sangpornsuk, Voravut Rungpradubvong, Tachawut Tiensantisuk, Pattranee Leelapattana, Ronpichai Chokesuwattanakul, Somchai Prechawat   +5 more
doaj   +1 more source

Reappraising Use of Flecainide for Atrial Fibrillation and Ventricular Arrhythmias in Structural Heart Disease Patients

Medicina
Background: Flecainide, a class Ic antiarrhythmic agent, has long been contraindicated in structural heart disease (SHD) due to findings of the Cardiac Arrhythmia Suppression Trial (CAST).
Dimitrios Tsiachris, Sotirios C. Kotoulas, Ioannis Doundoulakis, Christos-Konstantinos Antoniou, Michail Botis, Konstantinos Pamporis, Nikolaos Argyriou, Aikaterini-Eleftheria Karanikola, Panagiotis Tsioufis, Athanasios Kordalis, Konstantinos Tsioufis   +10 more
doaj   +1 more source

Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40‐hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target

British Journal of Clinical Pharmacology, 2019
THN102 is a novel combination of modafinil and low‐dose flecainide, targeting glial connexin activity to modulate modafinil effects. We investigated THN102 efficacy compared to modafinil and to placebo on vigilance and cognitive function during 40‐hour ...
F. Sauvet, Mégane Erblang, D. Gomez-Mérino, A. Rabat, M. Guillard, D. Dubourdieu, Hervé Lefloch, C. Drogou, Pascal Van Beers, C. Bougard, Cyprien Bourrrilhon, P. Arnal, W. Rein, F. Mouthon, F. Brunner-Ferber, D. Léger, Y. Dauvilliers, M. Chennaoui, M. Charvériat   +18 more
semanticscholar   +1 more source